CIK 0001701541
- Non-accelerated filer
- Smaller reporting company
Black Diamond Therapeutics, Inc.
Sign in to watch- Ticker
- BDTX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 814254660
- Phone
- +1 617-417-5868
- Business address
- 245 FIRST STREET, 18TH FLOOR, CAMBRIDGE, MA, 02142
- Former names
- Aset Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 48 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-12-16 | INGRAM ROBERT ALEXANDER FORMER DIRECTOR | Grant or award | +9,375 | $1.50 | $14K | 42,854 |
| 2022-09-16 | INGRAM ROBERT ALEXANDER Director | Grant or award | +6,584 | $2.62 | $17K | 33,479 |
| 2022-06-17 | INGRAM ROBERT ALEXANDER Director | Grant or award | +8,498 | $2.03 | $17K | 26,895 |
| 2022-06-10 | INGRAM ROBERT ALEXANDER Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2022-03-18 | INGRAM ROBERT ALEXANDER Director | Grant or award | +5,795 | $3.02 | $18K | 18,397 |
| 2021-12-17 | INGRAM ROBERT ALEXANDER Director | Grant or award | +3,296 | $5.31 | $18K | 12,602 |
| 2021-09-17 | INGRAM ROBERT ALEXANDER Director | Grant or award | +1,869 | $9.90 | $19K | 9,306 |
| 2021-06-18 | INGRAM ROBERT ALEXANDER Director | Grant or award | +1,255 | $12.95 | $16K | 7,437 |
| 2021-06-18 | INGRAM ROBERT ALEXANDER Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2021-03-18 | INGRAM ROBERT ALEXANDER Director | Grant or award | +677 | $24.01 | $16K | 6,182 |
| 2020-12-15 | INGRAM ROBERT ALEXANDER Director | Grant or award | +505 | $34.29 | $17K | 5,505 |
Page 1 of 1 · 11 trades